ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Argenica Therapeutics Limited

Argenica Therapeutics Limited (AGN)

0.11
0.013
(13.40%)
終了 7月3日 3:00PM

Argenica Therapeutics Limited (AGN) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
0.11
( 13.40% )
買値
0.105
売値
0.115
出来高
121,410
0.11 日の範囲 0.11
0.087 52 週間の範囲 0.79
時価総額
前日終値
0.097
始値
0.11
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
AUD 300,654
発行済株式数
128,456,712
配当利回り
PER
-1.26
1 株当たり利益 (EPS)
-0.08
歳入
1.01M
純利益
-9.8M

Argenica Therapeutics Limited について

Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke ... Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. The company was incorporated in 2019 and is based in Nedlands, Australia. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Nedlands, Australia
設立
2026
Argenica Therapeutics Limited is listed in the Healthcare sector of the オーストラリア証券取引所 with ticker AGN. The last closing price for Argenica Therapeutics was AUD0.10. Over the last year, Argenica Therapeutics shares have traded in a share price range of AUD 0.087 to AUD 0.79.

Argenica Therapeutics currently has 128,456,712 shares in issue. The market capitalisation of Argenica Therapeutics is AUD14.13 million. Argenica Therapeutics has a price to earnings ratio (PE ratio) of -1.26.

AGN 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.0054.76190476190.1050.110.08710838030.09351768DE
4-0.01-8.333333333330.120.140.0876213800.10572268DE
12-0.03-21.42857142860.140.1950.0873040470.11712045DE
26-0.19-63.33333333330.30.3450.0872446310.1682852DE
52-0.68-86.07594936710.790.790.0873040520.2638266DE
156-0.25-69.44444444440.360.9850.0871945480.46085263DE
260-0.1-47.6190476190.211.020.0871762980.45225843DE

AGN - Frequently Asked Questions (FAQ)

What is the current Argenica Therapeutics Limited share price?
The current share price of Argenica Therapeutics Limited is AUD 0.11
How many Argenica Therapeutics Limited shares are in issue?
Argenica Therapeutics Limited has 128,456,712 shares in issue
What is the market cap of Argenica Therapeutics Limited?
The market capitalisation of Argenica Therapeutics Limited is AUD 14.13M
What is the 1 year trading range for Argenica Therapeutics Limited share price?
Argenica Therapeutics Limited has traded in the range of AUD 0.087 to AUD 0.79 during the past year
What is the PE ratio of Argenica Therapeutics Limited?
The price to earnings ratio of Argenica Therapeutics Limited is -1.26
What is the cash to sales ratio of Argenica Therapeutics Limited?
The cash to sales ratio of Argenica Therapeutics Limited is 12.25
What is the registered address of Argenica Therapeutics Limited?
The registered address for Argenica Therapeutics Limited is 117 Broadway, Nedlands, Western Australia, 6009
What is the Argenica Therapeutics Limited website address?
The website address for Argenica Therapeutics Limited is argenica.com.au
Which industry sector does Argenica Therapeutics Limited operate in?
Argenica Therapeutics Limited operates in the Biotechnology & Life Sciences sector

AGN 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード